LXEO (Lexeo Therapeutics) Total Business Assets

LXEO (Lexeo Therapeutics) - company brandmark

Lexeo Therapeutics (LXEO) maintains its production base in New York laboratories, while batch manufacturing is delegated to vetted contractors to eliminate disruptions. This price action on GURU.Markets illustrates total assets at 215.48. Lexeo Therapeutics (LXEO) is developing treatments for Alzheimer's disease and cardiac pathologies, leveraging an innovative platform and the potential for acquisition by market behemoths.

LXEO - Lexeo Therapeutics, Inc. Company Total Assets over the range 02/21/2024 - 10/29/2026

Financial and market metric breakdowns for lexeotx.com (LXEO)

- stock value and consensus price forecast:
Market Price Lexeo Therapeutics, Inc.|LXEO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Lexeo Therapeutics, Inc.|LXEO - Total Company Value
- book capitalization information:
Equity per Share Lexeo Therapeutics|LXEO - Book Capitalization|Market Capitalization to Book Value Ratio lexeotx.com|LXEO - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Lexeo Therapeutics|LXEO - Long-Term Debt to Capital|Current Liabilities to Capital Lexeo Therapeutics, Inc.|LXEO - Company Total Debt|Debt to Book Value Ratio Lexeo Therapeutics, Inc.|LXEO - Company Long-Term Debts|Short-Term Debt Lexeo Therapeutics
Summary company analysis:Lexeo
Finished products of Lexeo Therapeutics

Developing gene therapies for Alzheimer's disease and cardiac pathologies requires colossal capital expenditures. A reverse calculation via ROA allows for the real-time tracking of the dynamics of Lexeo Therapeutics (LXEO) total resources and debt obligations. This indicator measures the total value of controlled assets, revealing the balance between equity and borrowed funds. Analyzing the total assets chart helps determine whether capacity growth is sustainable or excessively risky.

Direct competitors

Company Assets Tempus AI, Inc (TEM)|QGEN (Qiagen) - Company Total Assets|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Aggregate Company Assets Repligen Corp. (RGEN)|Avidity Corp - Total Business Assets|Company Total Assets CRSP (CRISPR Therapeutics AG)|Company Total Assets genedx.com WGS|RARE - Aggregate Company Assets|BEAM: Aggregate Company Assets|SRPT: Company Total Assets|Company Assets Twist Bioscience Corp (TWST)|Cumulative Company Assets TXG|Total Business Assets NTLA (intelliatx.com)|Company Total Assets STOK|BLFS - Company Assets|Aggregate Company Assets Wave Life Sciences Corp WVE|Maze Therapeutics Corp (MAZE) - Company Assets|SION: Cumulative Company Assets|Aggregate Asset Value PRME (primemedicine.com)|TSHA (Taysha Gene Therapies, Inc.) - Cumulative Company Assets|QURE: Aggregate Business Assets|MGTX (MeiraGTx PLC) - Company Total Assets|RGNX: Aggregate Asset Value|Company Total Assets SLDB|OCGN - Company Assets|Aggregate Company Assets PacBio PACB|Aggregate Asset Value BNTC|Design Pharma - Company Total Assets|RCKT - Company Total Assets|4D Molecular Therapeutics (FDMT) - Aggregate Company Assets|Total Asset Value of Company KRRO (Korro Bio)|EDIT (Editas Medicine) - Company Total Assets|Company Assets Silence Therapeutics PLC SLN|Cumulative Company Assets PRQR (ProQR Therapeutics N.V.)|Company Total Assets codexis.com (CDXS)|Sangamo Therapeutics - Cumulative Company Assets|Aggregate Business Assets NAUT (Nautilus Biotechnology, Inc.)|Metagenomi - Company Total Assets|Company Total Asset Base precisionbiosciences.com DTIL|GBIO: Company Total Assets|Cumulative Company Assets Boundless Bio Inc|Aggregate Company Assets Exicure Inc.|Celsion Corporation (IMNN) - Company Total Asset Base|Aggregate Company Assets Phio Pharmaceuticals (PHIO)|Aggregate Company Assets MBIO (mustangbio.com)|TransCode Therapeutics, Inc. - Cumulative Company Assets|BNGO: Total Business Assets|Applied DNA Sciences - Company Total Assets|Company Assets bluebirdbio.com|immunoprecise.com (IPA) - Aggregate Company Assets|Company Assets Omega Therapeutics Inc (OMGA)|OMIC (Singular Genomics Systems Inc) - Company Total Assets|Total Business Assets RGLS (Regulus)|Aggregate Company Assets Syros Pharmaceuticals (SYRS)|telesisbio.com - Total Business Assets|Company Total Assets TCON (TRACON Pharmaceuticals, Inc.)|Company Total Assets Unity Biotechnology Inc. UBX